Engineering hiPSC-derived tissue models for advanced amyloidosis research and therapy development

31 August 2024 (15:00 - 15:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Olalla Iglesias Garcia

CIMA University of Navarre, Pamplona, Navarra (Spain)

6 More presentations in this session

Presentation thumbnail

Incidence of acute cellular and antibody mediated rejection in heart transplantation from a tertiary care center

Doctor S. Mallick (New Delhi, IN)

Abstract Slides Video

Presentation thumbnail

Cells of the adult mouse cardiac conduction system in wild type and Nkx2-5 heterozygous loss-of-function mutation

Ms V. Strohmenger (DE)

Abstract Slides Video

Presentation thumbnail

The cardiac sympathetic co-transmitter neuropeptide-Y is pro-arrhythmic in human cardiomyocytes by lengthening activation-recovery interval

Mr R. Bloxsom (Oxford, GB)

Abstract Slides Video

Presentation thumbnail

Identification of genetic variants associated with exercise-induced atrial fibrillation in high-performing racehorses

Doctor M. Mattingsdal (Gjettum, NO)

Abstract Slides Video

Presentation thumbnail

Novel mitochondria-targeted therapy AP39 limits mitochondrial dysregulation and diastolic dysfunction in 2D & 3D human models of diabetic cardiomyopathy

Professor R. Ritchie (Melbourne, AU)

Abstract Slides Video

Access the full session

Session thumbnail

Heart failure: new scientific insights (2)

The Event

Event poster

ESC Congress 2024

31 August 2024 15:00 CET

You may be interested in

Congress Presentation

Human in vitro disease modeling of ATTR cardiac amyloidosis

Congress Presentation

The role of TTR in ATTR-CM disease and treatment

Congress Presentation

Transthyretin cardiac amyloidosis: pathophysiology and consequences

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources